Related Articles
<em>CREB1</em> acts via the miR‑922/<em>ARID2</em> axis to enhance malignant behavior of liver cancer cells
Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells
miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD
Upregulated microRNA-429 inhibits the migration of HCC cells by targeting TRAF6 through the NF-κB pathway
CYLD downregulation is correlated with tumor development in patients with hepatocellular carcinoma